Timing of routine infant vaccinations and risk of food allergy and eczema at one year of age

Background Epidemiological evidence suggests that routine vaccinations can have nontargeted effects on susceptibility to infections and allergic disease. Such effects may depend on age at vaccination, and a delay in pertussis vaccination has been linked to reduced risk of allergic disease. We aimed...

Full description

Saved in:
Bibliographic Details
Published inAllergy (Copenhagen) Vol. 71; no. 4; pp. 541 - 549
Main Authors Kiraly, N., Koplin, J. J., Crawford, N. W., Bannister, S., Flanagan, K. L., Holt, P. G., Gurrin, L. C., Lowe, A. J., Tang, M. L. K., Wake, M., Ponsonby, A.‐L., Dharmage, S. C., Allen, K. J.
Format Journal Article
LanguageEnglish
Published Denmark Blackwell Publishing Ltd 01.04.2016
Subjects
Online AccessGet full text
ISSN0105-4538
1398-9995
1398-9995
DOI10.1111/all.12830

Cover

More Information
Summary:Background Epidemiological evidence suggests that routine vaccinations can have nontargeted effects on susceptibility to infections and allergic disease. Such effects may depend on age at vaccination, and a delay in pertussis vaccination has been linked to reduced risk of allergic disease. We aimed to test the hypothesis that delay in vaccines containing diphtheria–tetanus–acellular pertussis (DTaP) is associated with reduced risk of food allergy and other allergic diseases. Methods HealthNuts is a population‐based cohort in Melbourne, Australia. Twelve‐month‐old infants were skin prick‐tested to common food allergens, and sensitized infants were offered oral food challenges to determine food allergy status. In this data linkage study, vaccination data for children in the HealthNuts cohort were obtained from the Australian Childhood Immunisation Register. Associations were examined between age at the first dose of DTaP and allergic disease. Results Of 4433 children, 109 (2.5%) received the first dose of DTaP one month late (delayed DTaP). Overall, delayed DTaP was not associated with primary outcomes of food allergy (adjusted odds ratio (aOR) 0.77; 95% CI: 0.36–1.62, P = 0.49) or atopic sensitization (aOR: 0.66; 95% CI: 0.35–1.24, P = 0.19). Amongst secondary outcomes, delayed DTaP was associated with reduced eczema (aOR: 0.57; 95% CI: 0.34–0.97, P = 0.04) and reduced use of eczema medication (aOR: 0.45; 95% CI: 0.24–0.83, P = 0.01). Conclusions There was no overall association between delayed DTaP and food allergy; however, children with delayed DTaP had less eczema and less use of eczema medication. Timing of routine infant immunizations may affect susceptibility to allergic disease.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0105-4538
1398-9995
1398-9995
DOI:10.1111/all.12830